Safety Profile of Musculoskeletal Contrast-Enhanced Ultrasound with Sulfur Hexafluoride Contrast Agent.
Christian FischerPierre KunzMarten StrauchMatthias H MunkJulian DollPublished in: Therapeutics and clinical risk management (2020)
The present analysis confirms the safety of musculoskeletal CEUS using sulfur hexafluoride contrast agent with a lower rate of AEs than that reported for other contrast agents even in elderly patients with concomitant diseases.